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Abstract
Background: Sternocostoclavicular hyperostosis (SCCH) is a rare, debilitating, chronic inflammatory disorder of the
anterior chest wall due to a chronic sterile osteomyelitis of unknown origin. SCCH is largely underdiagnosed and
often misdiagnosed. In individual cases it can remain unrecognized for years. The purpose of this study is twofold.
Firstly, to evaluate the psychological condition of SCCH patients, both in the sometimes quite extended pre-
diagnostic period between first manifestations and confirmed diagnosis of the disease, and in the current situation.
Secondly, to investigate the relationships between the pre-diagnostic and the current psychological conditions of
confirmed SCCH patients.
Methods: Structured interviews were held with 52 confirmed SCCH patients. Questionnaires were included to
assess posttraumatic stress symptoms, social support, aspects of pain, illness perceptions, self-reported health status,
and quality of life.
Results: SCCH patients reported stronger posttraumatic stress symptoms, more unfavorable illness perceptions,
lower health status, and poorer quality of life than healthy individuals and patients with other diseases or traumatic
experiences. Psychological distress in the pre-diagnostic period was associated with unfavorable conditions in the
current situation.
Conclusion: SCCH is an illness with serious psychological consequences. Psychological monitoring of patients with
unexplained complaints is recommended as long as a diagnosis has not been reached.
Background
Patients who suffer from rare diseases often encounter
difficulties that victims of more common disorders are
spared. Fewer health care providers have sufficient
knowledge and experience to handle a rare disease and
usually no or much fewer therapeutic options are avail-
able. Moreover, lack of awareness of the clinical mani-
festations of a rare disease may lead to diagnostic delay,
failure of diagnosis, and misdiagnosis. Recently, these
problems have been documented in a detailed report by
the European Organisation of Rare Diseases, which was
summarized in The Lancet [1,2]. In two surveys of a
total of 12,000 patients with 16 different rare diseases, it
was found that, with the exception of cystic fibrosis,
25% of the patients had to wait more than 3 years
before the correct diagnosis was established, and that
41% were initially misdiagnosed, including 7% who were
told that their symptoms were psychological or psychia-
tric. Eighteen percent of the patients had to find
answers on their own to obtain the correct diagnosis. In
19% of the patients, diagnostic delay led to loss of confi-
dence in the health-care system. Eighteen percent
experienced rejection by a health-care professional
because of disease complexity or associated symptoms. * Correspondence: w.a.van.der.kloot@umail.leidenuniv.nl
1Institute of Psychology, Leiden University, The Netherlands
Full list of author information is available at the end of the article
van der Kloot et al. Health and Quality of Life Outcomes 2010, 8:97
http://www.hqlo.com/content/8/1/97
© 2010 van der Kloot et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.The EURORDIS findings are paralleled by the results
from a study of our own research group on patients
with sternocostoclavicular hyperostosis (SSCH), a rare
inflammatory disease of the axial skeleton [3]. Fifty per-
cent of our patients had to wait between 3.5 and 36
years for a correct diagnosis, 40% were initially misdiag-
nosed, 4% were told that their symptoms were psycholo-
gical, and 35% had sometimes felt rejected by doctors or
nursing staff. In 23% the correct diagnosis was only
established after the patients obtained information from
sources outside their regular medical circuit.
SCCH is a rare chronic, inflammatory disorder of the
axial skeleton, caused by a chronic sterile osteomyelitis
with a predilection for the sternum, the medial ends of
the claviculae, and the upper ribs. The most common
clinical manifestations of SCCH include redness and
(usually painful) swelling in the sternoclavicular region
often associated with restricted and painful mobility of
the adjacent shoulder(s). Thirty to fifty percent of the
patients may develop pustulosis palmoplantaris, a chronic
sterile inflammation characterized by sterile pustules on
the palms of the hand or the soles of the feet, though not
necessarily simultaneously with the bone manifestations.
SCCH was first described as a separate entity in 1974 in
Japan and in 1975 in Germany [4,5]. In 1987, Chamot et
al. coined the term SAPHO (Synovitis, Acne, Pustulosis,
Hyperostosis, Osteitis) for a syndrome in which SCCH
was associated with generalized joint and skin manifesta-
tions [6]. The literature shows that SCCH is an ill-known
syndrome that may remain unrecognized for years [7-10]
and that it is largely underdiagnosed due to a lack of
awareness among physicians for the disorder [9-14].
Patients with SCCH have been described to go through a
“diagnostic odyssey” [12, p. 209] before a correct diagno-
sis was obtained [15,16] and some dramatic examples
were described of cases that were initially misdiagnosed
and treated incorrectly [16,17]. Recently, we have shown
that the duration of the interval between the first mani-
festations of SCCH and the establishment of its diagnosis
had some serious negative psychological and socioeco-
nomic consequences for SCCH patients [3].
The pre-diagnostic period
During the often quite extended interval between the
first manifestations of a rare disease and its correct diag-
nosis, patients live in a diagnostic vacuum as long as
their symptoms remain medically unexplained and lack
a descriptive diagnostic label. This situation, as Nettle-
ton, Watt, O’Malley, and Duffey [18] demonstrated,
made patients fear that their illness was “all in the
mind” (p. 207) and “not legitimate” (p. 207). It made
patients feel “marginalized by doctors” (p. 206), and
made them represent their illness in terms of “chaos
narratives” (p. 206) characterized by “confusion and
uncertainty” (p. 206) and “a merry-go-round of hope
and despair” (p. 206). Such strong feelings suggest that a
prolonged pre-diagnostic period is stressful and trau-
matic and may produce serious repercussions on the
mental health of the patients involved, for instance in
the form of post-traumatic stress symptoms.
Post-traumatic stress
The relationship between post-traumatic stress (PTS)
and physical illness has been documented in a variety of
studies. PTS following violent or life-threatening experi-
ences is often construed as a cause of or contributor to
physical illness [19,20] although there is reason for cau-
tion with this interpretation [21]. Moreover, it has been
observed that illness itself can be a traumatic condition
that produces PTS. PTS was observed in women suffer-
ing from breast cancer in several stages [22-24], in
patients after bone marrow transplantation for cancer
[25], and among patients who underwent acute medical
treatment in Intensive Care Units [26]. The latter study
suggested that “the presence of traumatic memories [ita-
lics added] is one of the most relevant aspects for the
development of PTSD-related symptoms” [26, p. 671].
Clinical levels of PTS were also found in women after
spontaneous abortion [27], after abortion for fetal
abnormality [28], after elective surgical abortion [29],
and after childbirth [30,31]. For some women, the
intense pain and feelings of helplessness during child-
birth constitute a severely traumatic experience to
which they may react with PTS [30,32]. In these cases (i.
e. cancer, ICU-hospitalization, abortion, childbirth), it
appears that the feelings and memories associated with
the illness or violent bodily experience are the traumatic
agents that produce or facilitate PTS.
In the interval between first symptoms and diagnosis,
SCCH-patients experience pain, swelling, and/or
restricted mobility of the shoulder girdle that are either
not medically explained and thus remain untreated, or
are incorrectly explained and consequently unsuccess-
fully treated. We hypothesized that in this situation,
which may be worsened by feeling rejected by health
professionals and others in the social environment,
patients may develop symptoms of PTS.
Social support
Several studies have shown that coping with stress and
traumatic events is positively influenced and moderated
by the social support individuals receive or perceive
[25,33-35]. Although some other studies [31,36] did not
find an effect of social support on PTS, we hypothesized
that social support will have a beneficial effect on PTS
in SCCH-patients.
The current situation
As SCCH is a chronic disease, a definitive cure cannot
be achieved when the diagnosis is finally established.
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the local inflammatory changes. However, even when
the inflammatory manifestations are controlled, patients
may retain some residual disability in the form of
chronic pain and limited mobility of the shoulder girdle
due to irreversible, degenerative changes in the structure
of the affected bones. To better understand how SCCH
may affect the life of patients with a confirmed SCCH
diagnosis, we compared their quality of life (QOL), ill-
ness perceptions, and self-reported health status to
those of patients with other diseases.
Objectives
Our first objective was to evaluate the psychological
condition of SCCH patients and the extent and serious-
ness of their problems both in the interval between first
manifestations and diagnosis of the disease, and in the
current situation, after the diagnosis had been estab-
lished for some time. Our second objective was to inves-
tigate the relationship between the pre-diagnostic
condition and the present-day situation of patients with
SCCH. We expected that problems such as PTS in the
pre-diagnostic period may have repercussions on QOL,
illness perceptions, and self-reported health status at a
later stage in the course of the illness. Moreover,
because several studies have shown social support to
h a v eap o s i t i v ee f f e c to nQ O L[37,38], we tested the
hypothesis that social support in the pre-diagnostic per-
iod is related to (perceived) physical and mental health
at the time of the study.
Materials and methods
The study was initiated and conducted by the Psychol-
ogy Institute of Leiden University. This institute does
not require ethical approval and does not comprise an
ethical commission. Design and execution of the study
followed the ethical standards of the American Psycho-
logical Association. The study was supported by the
Dutch SCCH Patient Association http://www.scch.nl,
which helped to recruit the majority of patients from its
members. Most patients were also under regular clinical
control of one of the authors (NATH) at the Depart-
ment of Endocrinology and Metabolic Diseases of the
Leiden University Medical Center (LUMC), a tertiary
referral center for patients with SCCH.
Patients
Fifty-seven patients with a definitive diagnosis of SCCH
were invited to participate in this study. Fifty-two of
them responded positively and were interviewed in their
homes by one of three trained interviewers: two
psychology Master students and one final-year medical
student. We estimated that these 52 respondents
encompassed the majority of Dutch patients with a
diagnosis of SCCH and were representative of this
population. The patients were contacted by telephone
and if they agreed to participate, a date and time were
set for the interview. Written informed consent was
obtained from all patients prior to the start of the
interviews.
Interviews
Interviews consisted of a structured set of questions on
gender, age, age at the time of the first manifestations of
SCCH, education, employment, and several aspects of
the patient’s medical and psychological condition both
in the pre-diagnostic period and in the present situation.
The patients were also interviewed about their trajec-
tories in the health care system between onset of the
disease and confirmed diagnosis (those results have
been published elsewhere [3]).
The interviewers asked most questions verbally. The
responses were written on protocol sheets and (after
permission) were registered on a voice recorder. During
the interview the respondents also completed several
questionnaires. To describe their condition in the pre-
diagnostic period, the patients were asked to localize
their complaints on drawings from the Dutch language
version of the McGill Pain Questionnaire (MPQ-DLV)
[39] and were presented with Dutch versions of the
Revised Impact of Event Scale (IES-R) [40] and the
Social Support Inventory (SSI) [41]. With regard to their
present situation, the patients filled out the complete
MPQ-DLV, the Dutch version of the Brief Illness Per-
ception Questionnaire (B-IPQ) [42], and the MOS
Short-Form General health Survey (SF-20) [43].
Questionnaires
The IES-R measures symptoms of PTS by means of 22
statements (e.g. “In the period when it was not yet clear
that my complaints were due to SCCH, I found it diffi-
cult to concentrate”) with four response categories
“never”, “rarely”, “sometimes”,a n d“often”,w h i c h ,u s i n g
the original scoring system, were coded as 0, 1, 3, and 5.
From these items scores were computed on the three
subscales intrusion, avoidance, and hyperarousal. These
subscales were subsequently combined to form the IES-
R-total score.
Five emotional impact statements (“my complaints
made me desperate”, “my complaints felt like a drama”,
“I was very concerned about my complaints”, “I was very
frightened about my complaints”,a n d“Iw a sv e r y
depressed about my complaints”) were presented with
response categories 0 = never, 1 = rarely, 2 = some-
times, and 3 = often.
The SSI contains 20 questions (e.g. “In the period
when it was not yet clear that your complaints were due
to SCCH, how often did somebody cheer you up?”) with
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what too infrequently, (3) just right, (4) somewhat too
often, and (5) far too often. The 5 and 4 responses were
recoded into 1 and 2, respectively, yielding scores that
measure satisfaction with support. Four subscales were
computed: emotional support, informative support,
instrumental support, and social companionship, which
also were aggregated into SSI-total.
The MPQ-DLV consists of four parts. The first part
shows two drawings of a nude, androgynous person,
seen from the front and from the back, on which the
respondents indicated the regions where they felt pain
or had other complaints. The drawings were scored by
superimposing a 0.5 × 0.5 cm grid and counting the
number of grid cells marked by the respondent. This
resulted into four variables: frontal-complaints-first
and dorsal-complaints-first concerning the first, pre-
diagnostic, manifestations of SCCH, and frontal-com-
plaints-now and dorsal-complaints-now for the present
situation. The second part consists of questions
regarding pain from which we selected “Do you ever
feel pain?” with response categories (1) never, (2) yes,
but the pain comes in waves and disappears between
the waves, (3) yes, the pain is always present but its
intensity varies, and (4) yes, the pain is always present
and has always the same intensity. The third part con-
sists of two 100 mm visual analogue scales (VAS) with
endpoints “no pain at all” and “unbearable pain”.O n
the first VAS, the respondents rated the intensity of
their current pain (VASnow). On the second VAS they
rated the intensity of their pain when it was least
intense (VASmin) and when it was most intense (VAS-
max). The last part of the MPQ-DLV consists of 20
sets of three or four pain describing adjectives. In each
set that contained adjectives that were applicable to
their pain, respondents marked the one adjective that
best described their pain. The sets of adjectives
describe three different qualities of pain: sensory (e.g.
burning, sharp, pinching), affective (e.g. exhausting,
fearful), and evaluative (e.g. annoying, unbearable).
From the marked adjectives four pain rating indices
(PRIS, PRIA, PRIE, PRIT) were constructed that indi-
cate the intensities of the sensory, affective, and eva-
luative qualities of pain, respectively, as well as the
total intensity.
The B-IPQ contains eight questions (e.g. “How long do
you think your illness will continue?”) each measuring a
perception of one’s illness. The perceptions (called dimen-
sions) are labeled consequences, time-line, personal con-
trol, treatment control, identity, concern, understanding,
and emotional response. Each response is measured on a
scale from 0 to 10 with the appropriate labels.
The SF-20 contains 20 questions that concern health
status and quality of life. The items (e.g. “Are you
restricted in bending, lifting, or stooping?”) are summar-
ized by six dimensions: physical functioning, role fulfill-
ment, social functioning, mental health, perceived
health, and physical pain. Higher scores indicate more
favorable conditions.
Analysis
Two of the authors categorized the responses to the
open questions. Interobserver agreement was “good” to
“perfect” with Kappa’s between 0.70 and 1.00 (quartiles:
0.83, 0.94, and 0.98). For the questionnaire data, Cron-
bach’s alphas, means, and standard deviations (SD) were
computed. Means of the present sample were compared
with means obtained from samples in other studies,
using analysis of variance (ANOVA) and Bonferroni
comparisons. Relationships among variables were stu-
died by means of Pearson product moment correlations
and various multivariate techniques, notably, multiple
regression, principal component analysis, and canonical
correlation analysis.
Results
The respondent group consisted of 46 women (88.5%)
and 6 men (11.5%) whose ages varied between 24 and
79 years (median: 56 yrs). The oldest complaint dated
back 49 years, the most recent one 2 years (median 11
yrs). The age at which the first complaints arose (age-
first) ranged from 15 to 72 years (median 41.5 yrs). The
time interval between the patient’s first consultation and
establishment of the diagnosis varied from 1 month to
36 years. In 4 cases, the complaints started before 1976,
that is, earlier than, or at the same time as the first pub-
lications on SCCH; therefore those patients could not
possibly have been diagnosed before 1976. For those
patients we have used 1976 as the year of first consulta-
tion. The maximum interval length then becomes 24
years with a mean of 5.6 ± 5.9 years and a median of
3.5 years. The 25% quartile was exactly 1 year; the 75%
quartile was equal to 8.75 years. The earliest SCCH
diagnosis among our respondents was established in
1988. The most recent diagnosis was confirmed in 2007,
the year our study was run. The median was reached in
2000; the 25% and 75% quartiles were in 1995 and 2003,
respectively
The pre-diagnostic interval
The frontal complaints at first manifestation of SCCH
ranged from 0 to 32 marked grid-cells (possible range:
0 - 111; mean = 4.58; SD = 6.65). The dorsal com-
plaints at first manifestations ranged from 0 to 50
(possible range: 0 - 134; mean = 3.15; SD = 8.65).
Sixty-one percent of the frontal and 59% of the dorsal
markings, respectively, were in the upper thoracic and
shoulder regions.
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interval
During the interval before diagnosis, were you able to carry on with your normal work and other activities?
No 45 86.5%
Yes 7 13.5%
How did you feel during the interval before diagnosis?
Worried, frightened 25 48.1%
Depressed, desperate, overwhelmed by disease 12 23.1%
Misunderstood, not taken seriously, angry 9 17.3%
Normal, matter of fact 6 11.5%
How did your environment react?
Worried, startled 15 28.9%
Helpful, empathic, supportive 21 38.5%
Empathy at first, later less 2 3.9%
Normal, no empathy, unbelief 10 19.2%
Patient did not tell environment about disease 4 7.7%
Did your environment support you?
Never 3 5.8%
Sometimes, little support 5 9.6%
Gave much support 24 46.2%
Support only from close family 17 32.7%
Patient did not need support 3 5.8%
What was the extent of the received support?
No support 6 11.5%
Little support, sometimes support 13 25.0%
Much support 33 63.5%
Did others doubt that you were ill?
Never, always taken seriously 23 44.2%
No doubt in close environment, rest doubted 12 23.1%
Doubt, did not think complaints were important 13 25.0%
Patient did not consider herself ill 1 1.9%
Environment did not know about disease 3 5.8%
Did you yourself sometimes doubt that you were ill?
No 43 82.7%
Sometimes 9 17.3%
Did others think your complaints were psychological, “all in the mind”?
No 35 67.3%
Yes, disease was psychological 15 28.8%
Affectation 2 3.8%
Did you yourself think that your complaints were psychological, “all in the mind”?
No 41 78.8%
Sometimes 11 21.2%
Did you sometimes feel guilty about your illness?
No 31 59.6%
Sometimes 3 5.8%
Often 18 34.6%
Were you sometimes not taken seriously by health-care providers?
No, always taken seriously 17 32.7%
Yes, by General Practitioner (GP) 13 25.0%
Yes, by some doctors (GP or specialist) 19 36.5%
Yes, by hospital staff 3 5.8%
How often were you not taken seriously by health-care providers?
Never 17 32.7%
Sometimes 27 51.9%
Often 8 15.4%
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the responses to the open questions concerning the per-
iod between first symptoms and definitive diagnosis of
SCCH. The majority of the respondents were seriously
affected by their disease, as 86.5% was no longer able
to perform their normal work or other activities,
and 88.5% felt worried, depressed, or misunderstood.
Although 78.9% of the patients reported support from
their environment, at least from their close relatives,
48.1% experienced that others had doubts about their
illness and 32.6% reported that others believed their ill-
ness to be psychological or a form of affectation. More-
over, 21.2% of the patients themselves sometimes
doubted they were really ill and thought their com-
plaints might be psychological. Some forty percent of
the respondents felt guilty, of whom 34.6% often. Two-
thirds (67.3%) reported that they (sometimes or often)
had not been taken seriously by their health-care provi-
ders, among whom their own general practitioners.
These data confirm all the major themes (uncertainty,
despair, guilt, “it is all in the mind”, marginalization by
doctors) that were found among the patients with an
unexplained illness in the study by Nettleton, et al. [18].
The five statements “desperate”, “drama”, “concerned”,
“frightened”,a n d“depressed”, which could be endorsed
on a scale from 0 (never) to 3 (often), had means and
SDs of, respectively, 1.4 ± 1.19, 1.29 ± 1.09, 1.71 ± 1.05,
1.08 ± 1.05, and 1.65 ± 1.08. The mean and SD of the
scales after summation was 7.13 ± 4.78. The Cronbach
Alpha reliability coefficient was .922. Thirteen (25%),
eight (15.4%), thirteen (25%), five (9.6%), and thirteen
(25%) respondents gave the response “often” to the five
questions. These results indicate that having an (initi-
ally) unexplained illness has serious psychological men-
tal consequences for a substantial number of patients.
PTS symptoms
Table 2 contains the means, SDs and ranges of our
respondents’ scores on the three subscales and the total
s c a l eo ft h eI E S - R .F o rc o m p a r i s o nw eh a v ea d d e dt h e
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women who recently gave birth [32] and 191 women
who had their pregnancies terminated because of fetal
abnormality [28].
ANOVAs showed significant overall differences (see
Table 2) among the means of the different samples. In
order to study differences among the means of the sepa-
rate samples, we performed 3 post hoc Bonferroni com-
parisons for each scale using a = .05/3 (two-tailed) and
critical t-value = ± 2.401 (df = 675). On all IES-R scales
and IES-R-total, the means of the scores of SCCH
patients were significantly greater (p < .0001) than those
of the other groups.
Social support
Table 3 contains the means and SDs of the SCCH
patients on the scales of the SSI. Where the possible
scores of the SSI subscales range from 5 to 15 and the
SSI-total from 20 to 60, the observed means of the
SCCH patients are located in the upper regions of the
possible scores, which means that our respondents have
felt on average rather satisfied with the experienced
degree of social support. This corroborates the data on
support in Table 1. As we could not find means and
SDs of other samples in the literature, we cannot com-
pare our SSI data with those of other studies.
To test the - directional - hypothesis that social sup-
port has a negative association with PTS symptoms, we
computed bivariate correlation coefficients between the
four IES-R scales and the five SSI scales and used one-
tailed tests of significance. All SSI scales had significant
negative correlations with hyperarousal and three SSI
scales (SSI-emotional, SSI-instrumental, and SSI total)
had significant negative correlations with IES-R total
(see Table 3). The latter three correlations are explained
by the correlations between the SSI scales and hyperar-
ousal, as all other coefficients were not significant. Thus,
it appears that hyperarousal (i.e. irascibility, hypervigi-
lance, concentration and sleeping problems) is tempered
by all four modes of social support. However, all corre-
lation coefficients are rather small. The SSI scale with
the highest correlation (SSI instrumental) explains
Table 2 Mean ± SD, number of items, range of observed scores, Cronbach’s a, and F-values of the subscales of the
Impact of Event Scale (Revised) observed in the present sample and in two comparison samples (means with equal
upper case superscripts are not significantly different)
IES-R scale
(# of items; range; a)
SCCH patients
n=5 2
Childbirth data
a
n = 453
Pregnancy termination data
b
n = 191
F-value
df = 2, 675
Intrusion
(8; 0 - 40; .866)
16.12
A ± 9.76 7.24
C ± 6.8 9.35
B ± 8.02 34.959**
Avoidance
(8; 0 - 36; .854)
16.83
A ± 9.69 2.13
C ± 4.2 5.64
B ± 7.54 153.220**
Hyperarousal
(6; 0 - 30; .843)
12.50
A ± 8.27 3.23
C ± 4.3 4.78
B ± 6.46 70.036**
Total
(22; 2 - 96; .931)
45.45
A ± 24.73 12.61
C ± 13.0 19.78
B ± 19.48 99.230**
aOlde et al. [32];
bKorenromp et al. [28]; ** = p < .0001.
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increased by adding the three other SSI scales as predic-
tors, because they are highly collinear (see below).
Principal component factor analysis of the three IES-R
subscales and the subscales of the SSI yielded two fac-
tors that together explained 78% of the variance. After
Oblimin-rotation, one factor coincided with the three
IES-R subscales and the other with the SSI subscales.
Factor scores of the two factors completely coincided
with, respectively, IES-R-total (r = .999) and SSI-total
(r = 1.000). The two oblique factors were almost per-
pendicular, with a correlation of -.244 (6% common var-
iance), which is barely significant at a = .05, one-tailed.
Therefore, the hypothesis that social support has a bene-
ficial effect on PTS is only weakly supported in the pre-
sent study.
Product-moment correlations were computed between
age-first, frontal-complaints-first, dorsal-complaints-first,
and diagnostic delay, on the one hand, and the four
IES-R and five SSI scales on the other hand. None of
the correlations with the IES-R scales were significant.
Age at first manifestations and diagnostic delay corre-
lated significantly with emotional support (resp. r =
.374, p =. 0 0 7 ;r = - 358, p = .010) and with social com-
panionship (resp. r = .327, p = .019; r = -.347, p = .013).
Diagnostic delay also had significant correlations with
SSI informative support (r =- . 3 4 2 ,p = .014) and SSI
total (r = -.356, p = .010). The positive correlations
between age-first and the two SSI scales, might be
explained by the fact that the respondents who fell ill at
an older age had a more elaborate social network (e.g.
spouse and children) to provide support. The negative
correlations between diagnostic delay and the three
social support scales could mean that social support is
relatively short lived: initially strong, it probably wanes
with the persistence of unexplained complaints.
Reaction to diagnosis
Responses to the interview questions “Did something
change for you when it was established with certainty
that you had SCCH?” and “Did you feel better or worse
than before the diagnosis?” overlapped and were there-
fore combined. Twelve patients (23.1%) felt better
because “now there was clarity, it had a name, it was
real”, 11 patients (21.2%) felt relief because treatment
was possible and they could make adaptations, 5
patients (9.6%) felt relief because it was nothing more
serious such as cancer or rheumatoid arthritis, 9
patients (17.3%) reported ambiguous feelings: they felt
relief because of more clarity but also realized they had
a chronic disease. Three patients (5.8%) said they felt
worse after the diagnosis was established, 2 patients
(3.9%) reported no change at all, and 10 (19.2%) gave
ambiguous answers containing positive and negative
elements.
Current condition
Clinical symptoms
On the frontal-complaints-now drawing of the MPQ-
DLV, the patients marked on average 7.12 (SD = 9.43)
grid cells; on the dorsal-complaints-now variable the
mean was 5.23 (SD = 8.04). In both cases these means
were significantly higher (t = 2.152, p = .036 and t =
2.009, p = .05; df = 51, resp.) than the means on frontal-
complaints-first and dorsal-complaints-first, suggesting a
deterioration of symptoms over time.
Four patients (7.7%) reported they never had pain, 13
patients (25%) had pain that came in waves with symp-
tom-free periods, in 32 patients (61.5%) the pain was
continuous but of variable intensity, and in 3 patients
(5.8%) pain was continuous with no difference in inten-
sity. Mean scores and SDs of the visual analogue scales
for present pain (VASnow), minimum pain (VASmin),
and maximum pain (VASmax) were 35.50 ± 27.41,
18.54 ± 17.87, and 74.33 ± 25.87, respectively. These
means, although higher, do not differ significantly from
those of a Dutch sample [44] of 227 persons receiving
physiotherapy for mobility problems (VASnow = 29.43
± 22.64, VASmin = 15.36 ± 14.37, VASmax = 67.17 ±
23.82). In the present study, pain rating indices for the
sensory (PRIS), affective (PRIA), and evaluative qualities
(PRIE) of pain had means and SDs of 9.29 ± 6.96, 3.46
± 3.05, 4.27 ± 2.58. The mean of the total pain rating
index (PRIT) was 17.02 ± 11.40. Conservative t-tests
using df = 51 showed that all means were significantly
Table 3 Mean ± SD, number of items, observed and possible range, Cronbach’s a, and correlations with hyperarousal
and IES-R-total of the Social Support Inventory scales
Correlations with
Scale name Mean ± SD Number of items Range of scores
a Cronbach’s a hyperarousal IES-R-total
Emotional support 12.70 ± 2.43 5 5 - 15 .842 -.294 (.018
b) -.250 (.039
b)
Instrumental support 12.02 ± 2.60 5 5 - 15 .742 -.380 (.003
b) -.265 (0.30
b)
Social companionship 12.17 ± 2.85 5 5 - 15 .844 -.288 (.020
b) -.206 (.074
b)
Informative support 12.39 ± 2.54 5 5 - 15 .782 -.236 (.048
b) -.166 (.123
b)
SSI total 49.29 ± 9.10 20 20 - 60 .931 -.343 (.007
b) -.253 (.037
b)
aThe ranges of the observed scores were equal to the ranges of the possible scores.
b One-tailed probability.
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than the means of the patients undergoing physiother-
apy reported in [44] (PRIS: 5.80 ± 4.08; PRIA: 1.83 ±
1.97; PRIE: 3.37 ± 1.74; PRIT: 11.00 ± 7.03). These data
suggest that the pain experienced by SCCH patients is
similar or worse than the pain of the general, heteroge-
neous, population of individuals with usually painful
mobility complaints who are treated by physiotherapy.
Limitations and functioning
Nineteen respondents (36.5%) held jobs, 14 of whom
(26.9%) part-time. Ten respondents (19.2%) were unem-
ployed, 10 (19.2%) were retired, and 13 patients (25%)
were on social benefits for permanent disability (regu-
lated by Dutch national law). Among the 42 SCCH
patients who were either unemployed, worked part-time,
or were on social benefits, 22 (42.3% of the total) attrib-
uted this to their disease. This indicates that in a sub-
stantial number of cases SCCH is associated with
debilitating limitations that affect the socio-economic
situation of patients.
Table 4 contains the means, SDs, ranges, and Cron-
bach’s alphas of the subscales of the SF20. Also shown
are the means and SDs reported by Sonino et al. [45] of
86 patients with various forms of pituitary disease and
86 healthy respondents used as controls. ANOVAs
yielded significant overall F-values (Table 4). Bonferroni
comparisons using a = .05/3 showed that all groups dif-
fered significantly from each other as regards physical
functioning, health perceptions, and pain, with the
SCCH patients having the least favorable scores. Regard-
ing role functioning, the SCCH patients did not differ
significantly from patients with pituitary disease but had
significantly lower means than the healthy control
group. The same pattern of results was obtained for
social functioning and mental health. In sum, all means
of the SCCH patients were significantly lower than
those of the healthy group, and consistently lower
(though not always statistically significant) than those of
the pituitary patients.
Illness perceptions and disease acceptance
Table 5 contains the means and SDs of the SCCH
patients on the eight dimensions of the B-IPQ, as well
as the means of two groups of patients (with type 2
diabetes and asthma) which were selected for compari-
son from a study by Broadbent et al. [46]. Type 2 dia-
betes and asthma are chronic conditions that can be
relatively well-controlled by medication and personal
life-style, though diabetes may have serious long-term
complications. ANOVAs showed significant overall dif-
ferences (Table 5) among the three patient groups on
all B-IPQ variables except timeline. The latter result
suggests that all groups were equally aware of the
chronic nature of their diseases. Bonferroni compari-
sons with a =. 0 5 / 3s h o w e dt h a ta sr e g a r d sc o n s e -
quences (i.e. the perceived impact of one’s illness)
SCCH patients had significantly higher means than
asthma patients but did not differ from patients with
diabetes. A possible explanation is that diabetes and
SCCH are conditions that are continuously present,
whereas asthma usually manifests itself in acute
exacerbations that are spaced in time. SCCH patients
perceive lower personal and treatment control, and
experience more physical complaints (the dimension
“identity”) than patients with asthma and diabetes.
This probably reflects the fact that there is as yet no
standard treatment for SCCH and that various applied
Table 4 Mean, SD, number of items, observed range, Cronbach’s a, and F-values of the SF20 scales observed in the
present study and among patients and healthy controls in a comparison study (means with equal upper case
superscripts are not significantly different)
SF20-scale
(# of items; observed range; a)
SCCH patients
n=5 2
Pituitary disease ANOVA F-value;
df = 2, 221
Patients
c
n=8 6
Controls
c
n=8 6
Physical functioning
a
(6; 6 - 12; .673)
8.44
A ± 1.58 26.6
B ± 3.7 28.6
C ± 2.1 983.36 **
Role functioning
a
(2; 2 - 4; .766)
2.46
A ± .75 2.8
A ± 1.5 3.7
B ± .7 25.237 **
Social functioning
a
(1; 1 - 6; –)
4.33
A ± 1.21 4.8
A ± 1.7 5.7
B ± .7 20.948 **
Mental health
a
(5; 5 - 30; .933)
21.61
A ± 5.13 22.8
A, B ± 5.9 24.6
B ± 3.6 6.417*
Health perceptions
a
(5; 5 - 30; .745)
14.08
A ± 3.91 19.6
B ± 4.3 22.8
C ± 2.4 95.857 **
Pain
b
(1; 1 - 5; –)
3.63
A ± 1.27 2.1
B ± 1.2 1.7
C ±.8 53.909**
aHigher values indicate better functioning and health.
b Higher values indicate more pain.
cSonino et al. [45], the data of the Sonino et al. study were
transformed to make them comparable to the means of the SCCH study. * p < .002. ** p < .00001.
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trolling symptoms or disease progression. Life-style
appears to have limited influence on symptomatology
in SCCH. Regarding coherence, concern, and emo-
tional response, the SCCH patients did not differ from
patients with asthma, but both groups had significantly
lower means than the diabetes patients. This may be
due to the fact that diabetes is a much better under-
stood disease, treatment is well-established, and
patients are well aware of its possible serious conse-
quences if left untreated.
The patients answered several open questions con-
cerning the acceptance for their illness by themselves
and their social environment. Twenty-two patients
(42.3%) said they accepted their disease, 16 (30.8%)
accepted their disease but found it difficult to do so,
and 12 (23.1%) did not accept that they were ill. Two
patients (3.9%) gave contradictory responses. Twenty-
four patients (46.2%) consider e di td i f f i c u l tt ol i v ew i t h
SCCH, in 22 cases (42.3%) because of the limitations
caused by the illness and in two cases (3.8%) because of
anxiety and concern about the future. Twenty-eight
patients (53.8%) did not find it difficult to live with
SCCH, 23 (44.2%) because they had learnt to adapt to
their illness and 5 (9.6%) because treatment was effec-
tive. Thirty-four respondents (65.4%) reported that they
experienced sufficient understanding for their illness in
their environment, whereas 14 (26.9%) reported insuffi-
cient understanding and 4 (7.7%) felt only understood
by their partner and the persons nearest to them.
Thirty-six respondents (69.2%) experienced no problems
with the reactions of their environment; 4 patients
(7.7%) had experienced such problems in the past, and
12 (23.1%) experienced problems in the present situa-
tion. Twelve respondents (23.1%) had experienced pro-
blems in their jobs, with finding new jobs, or getting
functions adapted to their limitations. Nine patients
(17.3%) had difficulties obtaining insurance or applying
for social benefits.
Relationships between pre-diagnostic and current
conditions
As the variables describing the pre-diagnostic condition
and those concerning the present-day situation are
numerous and internally collinear, data reduction was
necessary before we could study their relationships
meaningfully. Above, we already reported that the IES-R
scales intrusion, avoidance, and hyperarousal can be
summarized by their total (IES-R-total) and that the SSI
scales can be represented by SSI-total without significant
loss of information. In a similar way (i.e. principal com-
ponent analysis) we found that the rating scales measur-
i n gd e s p a i r ,d r a m a ,c o n c e r n ,f r i g h t ,a n dd e p r e s s i o n
could be reduced to one factor that explained 76.4% of
their variance. Scores on this factor were perfectly corre-
lated with the sum of the five variables. Therefore, we
have used this sum in our final analyses, and named it
depressed-total, because depressed had the highest
loading.
The SF20 subscales and the B-IPQ dimensions were
submitted to principal component analysis and hierarch-
ical cluster analysis to explore which scales could be
joined. All SF20 scales except SFpain could be aggre-
gated into one summary variable. We therefore com-
puted the total of the first five SF20 subscales and
labeled this new variable SF-general-health.
Among the B-IPQ dimensions, one new variable
(BIPQ-impact) was constructed by summing conse-
quence, identity, concern, and emotional response, as
these variables had extensive communalities. We also
summed the dimensions treatment control and coher-
ence. As the latter variables suggest understanding of
the disease, we labeled their sum BIPQ-cognition.
Because timeline and personal control showed less asso-
ciation with the other BIPQ dimensions they were used
separately in the analyses.
We performed multiple regression analyses with age-
first, frontal-complaints-first, dorsal-complaints-first,
IESRtotal, SSItotal, depressed-total, and diagnostic delay
Table 5 Means and SDs on the eight B-IPQ dimensions and two comparison samples (means with equal upper case
superscripts are not significantly different)
SCCH patients Asthma patients
a Diabetes 2 Patients
a F-value (p)
B-IPQ scale n = 52 n = 309 n = 119 df = 2, 477
Consequences 5.63
A ± 2.80 3.5
B ± 2.3 4.7
A ± 2.9 21.575 (< .0001)
Timeline 9.17 ± 1.86 8.8 ± 2.2 9.2 ± 1.9 1.920 (.1478)
Personal control 5.31
A ± 2.35 6.7
B ± 2.4 6.7
B ± 2.3 7.9729 (.0004)
Treatment control 6.8
A ± 2.37 7.9
B ± 2.0 8.0
B ± 2.3 6.660 (.0014)
Identity 6.21
A ±2.30 4.5
B ± 2.3 4.6
B ± 2.8 11.153 (< .0001)
Concern 4.77
A ± 3.26 4.6
A ± 2.8 7.0
B ± 3.1 2.520 (< .0001)
Coherence 6.15
A ± 2.54 6.5
A ± 2.6 7.9
B ± 2.3 15.222 (< .0001)
Emotional response 4.04
A ± 3.21 3.3
A ± 2.9 4.3
B ± 3.3 5.192 (.0059)
a Broadbent et al. [46].
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plaints-now, VASnow, VASmin, VASmax, PRIS, PRIA,
PRIE, BIPQ-cognition, timeline, personal control, BIPQ-
impact, SFtotal, and SFpain, respectively. The results,
listed in Table 6, show that all current condition vari-
ables except personal control can to some extent be pre-
dicted by one or more pre-diagnostic variables with
statistical significance. Our data also show that all pre-
diagnostic variables, except IES-R-total, contribute to
one or more of the predictions. The most important
predictors (in terms of number of contributions) are
SSI-total, Age-first, Depressed-total, and dorsal-com-
plaints-first. SSItotal has positive contributions to vari-
ables indicating favorable conditions (SFtotal and
BIPQcognition) and contributes negatively to variables
that express unfavorable aspects (frontal-complaints-
now, dorsal-complaints-now, VASnow, PRIA, and
SFpain). Depressed-total has positive relations with the
(unfavorable) VASmax, PRIA, and BIPQimpact, whereas
it contributes negatively to the (favorable) SFtotal. The
contributions of age-first and dorsal-first, are, however,
more difficult to understand.
To clarify the above results, we performed a canonical
correlation analysis (CANCOR) by means of SPSS
MANOVA [47-49]. CANCOR investigates the relation-
ships between two sets of variables by simultaneously
looking for principal components in both sets under the
restriction that the correlation between the first compo-
nent in Set 1 and the first component in Set 2 is maxi-
mized. The same is required of the subsequent
dimensions. The principal components (also called
canonical axes or dimensions) can be interpreted by
means of their loadings, that is, the correlations between
the components and the original variables. Interpreta-
tion is often enhanced by graphs in which the compo-
nents are represented by orthogonal dimensions and the
variables by arrows whose coordinates on the dimension
are given by the loadings.
In our case, the first set of variables consisted of age-
first, frontal-complaints-first, dorsal-complaints-first,
SSItotal, IES-R-total, depressed-total, and diagnostic
delay. The second set contained frontal-complaints-now,
dorsal-complaints-now, VASnow, VASmin, VASmax,
PRIS, PRIA, PRIE, BIPQ-cognition, timeline, personal
control, BIPQ-impact, SFtotal, and SFpain. CANCOR
yielded two components (canonical axes) with statisti-
cally significant correlations (r1 = .911, p < .001; r2 =
.830, p < .017). Figure 1 displays the loadings of the
variables on the canonical axes.
The loadings of the current condition variables on the
horizontal axis suggest that this dimension reflects
apperceptions of health because the rightmost end is
defined by SFtotal, i.e. general perceived health (higher
scores denote better health), and the leftmost end by
BIPQ-impact and PRIA, which measure negative affec-
tive reactions to illness and pain. The lower end of the
vertical axis is defined by BIPQ-cognition and timeline.
This possibly indicates that individuals with a better
understanding of their illness and its treatment have
clearer ideas about the chronic character of SCCH.
Table 6 Multiple regression coefficients and standardized regression weights for predicting variables representing
present-day conditions from variables representing pre-diagnostic aspects
Pre-diagnostic variables (predictors)
Present-day variables (dependents) Age-first Frontal-first Dorsal-first IESR-total SSI-total Depressed-total Delay R
Frontal-now
a - .304* .323* - -.355** - - .647**
Dorsal-now
b - . . 627** - -.428** - - .738**
VASnow
c - - - - -.296* - - .296*
VASmin
d - - - - - - .413** .413**
VASmax
e - - - - - .418** - .418**
PRIS
f -.428** - - - - - - .428**
PRIA
g - - .255* - -.252* .543** - .722**
PRIE
h -.355* - - - - - - .355*
SFpain
i - - - - -.284* - - .284*
SFtotal
j - - - - .387** -.404** - .653**
BIPQimpact
k -.243* - - - .619** - .730**
BIPQcognition
l -.317* - -.447** - .332* - - .510**
Timeline -.369** - - - - - - .369**
Personal control - - - - - - - -
aFrontal-now = frontal area indicated as presently painful;
bDorsal-now = dorsal area indicated as presently painful;
cVASnow = visual analogue scale score of
present pain;
dVASmin = visual analogue scale score of minimal pain;
eVASmax = visual analogue scale score of maximal pain;
fPRIS = MPQ pain rating index
(sensory);
gPRIA = MPQ pain rating index (affective);
hPRIE = MPQ pain rating index (evaluative);
iSFpain = pain score measured by SF20;
jSFtotal = total of SF20
subscales physical functioning, role fulfillment, social functioning, mental health, and perceived health;
kBIPQimpact = sum of BIPQ consequence, identity,
concern, and emotional response;
lBIPQcognition = sum of BIPQ treatment control and coherence.
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now and frontal- and dorsal-complaints-now.
The loadings of the pre-diagnostic variables confirm
our interpretation of the horizontal axis: its left extreme
is defined by depressed-total and IES-R-total, variables
which measure strong affects. Thus, strong negative feel-
ings in the pre-diagnostic period are associated with
strong negative affects at the time of the interview. The
high positive loadings of SSI-total on Axis 1 show that
social support may counteract such negative affects. The
direction of SSI-total explains its role in the regression
analyses: it runs into the same direction as the favorable
SFtotal and BIPQcognitions, and in the opposite direc-
tion of the unfavorable frontal-now, dorsal-now, VAS-
now, and PRIA. Depressed-total has high loadings on
the unfavorable end of Axis 1, which explains its posi-
tive weights in the prediction of BIPQimpact, PRIA, and
VASmax and its negative weight in predicting SFtotal.
Although IES-R-total loads highly on the negative end
of Axis 1, it played no role in any of the regression ana-
lyses. Figure 1 shows why: IES-R-total, depressed-total,
and SSI are strongly interrelated (collinear) and cannot
therefore be entered together in a regression analysis.
The larger loadings of SSI-total and depressed-total
explain their precedence over IES-R-total.
The second axis has high loadings of frontal-com-
plaints-first and age-first, that is, patients with more
anterior (chest wall) complaints and those who were
older at the onset of SCCH tend to have higher scores
on VASnow and on frontal-complaints-now at a later
date. Interestingly, frontal-complaints-now and dorsal-
complaints-now have higher (negative) loadings on the
first axis than on the second axis. This means that
these ‘objective’ indicators of SCCH in the present
situation are also associated with affective reactions in
the past.
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Figure 1 Loadings of pre-diagnostic variables and present-day variables on two canonical axes. Each variable is a vector in the canonical
space; for legibility we have only drawn vectors for the pre-diagnostic variables. Vector lengths indicate their importance in the relationship
between the two sets of variables.
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The above results consistently indicate that the average
patient with SCCH experienced serious psychological
problems both in the current situation at the time of
the interview and in the pre-diagnostic period between
first manifestations of the disease and establishment of
the diagnosis of SCCH. With respect to the pre-diagnos-
tic period, patients reported affect and behavior that
classify as PTS symptoms. Comparisons with reference
groups made it clear that SCCH patients had signifi-
cantly higher scores on measures of PTS than women
who had experienced pregnancy termination because of
fetal abnormality, and women three months after child-
birth [28,32]. We speculate that the traumatic experi-
ences of having an unwanted abortion, however sad, or
giving birth, however violent, have a shorter duration
than being victim of an as yet unexplained and thus
untreatable illness, which can be construed as a chronic
stressor. It should be noted here, that the IES-R ques-
tionnaire we used, measures PTS symptoms,a n dd o e s
not yield a formal PTSD diagnosis. Although some
authors would argue that serious physical illness does
not meet the current DSM-IV definition of a traumatic
event, the present study is in line with others that have
documented elevated levels of PTS after breast cancer
[22-24], bone marrow transformation for cancer [25],
and acute medical treatment in Intensive Care Units
[26]. Regardless of the exact demarcation of the trauma
concept, the present study demonstrates that our SCCH
patients reported elevated levels of intrusion, avoidance,
and hyperarousal symptoms in response to their illness.
SCCH patients reported fair to good social support
during the pre-diagnostic period. We found that support
was greater in patients who were older during the pre-
diagnostic interval, which is possibly explained by the
fact that older persons have more stable and more inti-
mate social networks, which stood the test of time. We
also found that social support was inversely related to
diagnostic delay, indicating that this form of support
may diminish as the unexplained illness lasts longer.
Our expectation that social support would have a bene-
ficial effect on PTS was indeed confirmed, although the
correlation found was very weak.
SCCH patients reported equal or more pain in their
current situation than a comparison group of patients
treated with physiotherapy for (painful) mobility com-
plaints [44]. They also reported more pain and poorer
physical functioning than patients with pituitary disease
[45]. Physical, social, and role functioning, as well as
pain and perceived physical and mental health were
consistently worse in SCCH patients than in healthy
controls [45]. Illness perceptions were comparable to
those of patients with asthma and type 2 diabetes, with
various significant differences which indicated that
patients were aware of important aspects of their parti-
cular illnesses.
We have demonstrated significant associations between
data reported about the pre-diagnostic period and
responses concerning the situation at the time of the
interview. Strong perceptions and feelings about one’s
health (i.e. PTS symptoms, despair, drama, concern, fear,
and depression) in the pre-diagnostic period are related
to negative health apperceptions in the present time.
Diagnostic delay was found to be negatively related to
social support and positively related to minimum pain.
In a recent publication [3] we established that, when
controlling for age, diagnostic delay was also positively
related to maximum pain, affective pain rating (PRIA),
the BIPQ scales emotions and consequences, and unem-
ployment/disability. Diagnostic delay was also negatively
related to the SF20-scales role fulfillment and social
functioning, and hours worked per week.
Because our study is retrospective with regard to the
pre-diagnostic period, which for some patients occurred
many years previously, it is possible that some or many
respondents had no accurate recall of their physical and
psychological conditions at that stage. This could repre-
sent two types of problems. First, the responses to the pre-
diagnostic questions may contain random components
that could be relatively large, leading to low reliability and
lower correlations (attenuation). Since we obtained many
sizeable correlations among thep r e - d i a g n o s t i cv a r i a b l e s
and between the latter and some of the present-day vari-
ables, this possible attenuation problem has not prevented
us from finding some interesting relationships. However, it
is still possible that unreliability may have precluded the
discovery of additional interesting or important relation-
ships. A second possibility is that respondents colored
their responses to the pre-diagnostic questions on the
basis of their present feelings and cognitions. Patients who
felt better (worse) now might tend to report more (un)
favorably about their past condition. In that case we would
expect many (very) high correlations among most of the
variables concerning the pre-diagnostic period. Indeed, we
did find several high correlations, for example, within the
scales measuring PTS and within those measuring social
support, but not between those sets of variables. We also
found that feelings of worry, fright, drama, concern, and
depression could be reduced to one dimension, but this
dimension did not have extremely high correlations with
other pre-diagnostic variables. We can therefore conclude
that potential retrograde coloring of responses did not ser-
iously influence our results. We would like to stress that
prospective research into the effects of pre-diagnostic con-
ditions on later illness experience is practically impossible
in the case of rare diseases such as SCCH.
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taneously with the present-day variables, we cannot be
certain that the associations found between both sets
imply that the present-day condition is caused or influ-
enced by the pre-diagnostic situation. Nevertheless, the
arguments presented above and the general results sug-
gest that such an influence is probable.
Conclusions
SCCH is an illness with serious consequences both in
the pre-diagnostic period and after the diagnosis is
established. SCCH patients reported relatively strong
PTS symptoms, several unfavorable illness and health
status perceptions, impaired quality of life, and consider-
able pain. Moreover, negative psychological states and
lack of social support in the pre-diagnostic interval pre-
dict negative feelings and cognitions long after the diag-
nosis has been established. This implies that health care
professionals should be alert for stress and other psy-
chological problems of patients with unexplained
c h r o n i cc o m p l a i n t sa sl o n ga sad i a g n o s i si sn o te s t a b -
lished, and that extensive efforts should be made to
shorten this period.
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